Biochemical and pharmacological consequences of the interaction between methotrexate and ketoprofen in the rabbit.

por Perrin, A., Milano, G., Thyss, A., Cambon, P., Schneider, M.
Publicado 1990

Comparison of natural killer activity during the first and second halves of the menstrual cycle in women.

por Thyss, A., Caldani, C., Bourcier, C., Benita, G., Schneider, M.
Publicado 1984

Reevaluation of alkaline phosphatase measurement during Hodgkin's disease by electrophoretic isoenzyme separation.

por Thyss, A., Schneider, M., Caldani, C., Viot, M., Bourry, J.
Publicado 1985

Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.

por Thyss, A., Schneider, M., Santini, J., Caldani, C., Vallicioni, J., Chauvel, P., Demard, F.
Publicado 1986

Very Late Local Relapse of Ewing's Sarcoma of the Head and Neck treated with Aggressive Multimodal Therapy

por Thariat, J., Italiano, A., Peyrade, F., Birtwisle-Peyrottes, I., Gastaud, L., Dassonville, O., Thyss, A.
Publicado 2008

5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer.

por Santini, J., Milano, G., Thyss, A., Renee, N., Viens, P., Ayela, P., Schneider, M., Demard, F.
Publicado 1989

Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescue.

por Thyss, A., Milano, G., Etienne, M. C., Paquis, P., Roche, J. L., Grelier, P., Schneider, M.
Publicado 1989

No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion.

por Fleming, R. A., Milano, G. A., Etienne, M. C., Renée, N., Thyss, A., Schneider, M., Demard, F.
Publicado 1992

Continuous 5-day regional chemotherapy by 5-fluorouracil in colon carcinoma: pharmacokinetic evaluation.

por Boublil, J. L., Milano, G., Khater, R., Bourry, J., Thyss, A., Bruneton, J. N., Renée, N., Philip, C., Namer, M.
Publicado 1985

Expression of P-glycoprotein restricted to normal cells in neuroblastoma biopsies.

por Favrot, M., Combaret, V., Goillot, E., Wagner, J. P., Bouffet, E., Mazingue, F., Thyss, A., Bordigoni, P., Delsol, G., Bailly, C.
Publicado 1991

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study

por Mouriaux, F, Servois, V, Parienti, J J, Lesimple, T, Thyss, A, Dutriaux, C, Neidhart-Berard, E M, Penel, N, Delcambre, C, Peyro Saint Paul, L, Pham, A D, Heutte, N, Piperno-Neumann, S, Joly, F
Publicado 2016

Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

por Bouffet, E., Doz, F., Demaille, M. C., Tron, P., Roche, H., Plantaz, D., Thyss, A., Stephan, J. L., Lejars, O., Sariban, E., Buclon, M., Zücker, J. M., Brunat-Mentigny, M., Bernard, J. L., Gentet, J. C.
Publicado 1998

Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology

por Minard, V, Hartmann, O, Peyroulet, M C, Michon, J, Coze, C, Defachelle, A S, Lejars, O, Perel, Y, Bergeron, C, Boutard, P, Leverger, G, Stephan, J L, Thyss, A, Chastagner, P, Couillault, G, Devalck, C, Lutz, P, Mechinaud, F, Millot, F, Plantaz, D, Rialland, X, Rubie, H
Publicado 2000